WO2006026912A1 - An implantable artificial heart valve and implanting and retracting device - Google Patents
An implantable artificial heart valve and implanting and retracting device Download PDFInfo
- Publication number
- WO2006026912A1 WO2006026912A1 PCT/CN2005/001398 CN2005001398W WO2006026912A1 WO 2006026912 A1 WO2006026912 A1 WO 2006026912A1 CN 2005001398 W CN2005001398 W CN 2005001398W WO 2006026912 A1 WO2006026912 A1 WO 2006026912A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- valve
- heart valve
- wire
- prosthetic heart
- tube
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/2436—Deployment by retracting a sheath
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0054—V-shaped
Definitions
- the present invention relates to an alternative to human tissue and an implant and recovery device thereof, and more particularly to an interventional prosthetic heart valve and an implant and recovery device therefor. Background technique
- the heart is the most important organ of the human body.
- the heart is divided into two parts, each part including the atria and the ventricle.
- the left and right atrium and the left and right ventricles are separated by atrial septum and a septal compartment, respectively.
- There are four heart valves in the heart namely the tricuspid valve, the pulmonary valve, the mitral valve, and the aortic valve.
- four heart valves play a vital role.
- the hypoxic blood of the systemic circulation enters the right atrium through the vena cava, and then enters the right ventricle through the tricuspid valve.
- the right ventricle contracts to press the blood into the pulmonary circulatory system through the pulmonary valve.
- the blood After the pulmonary oxygen saturation, the blood returns to the left atrium through the pulmonary vein.
- the mitral valve reaches the left ventricle, and the left ventricle contracts to transfer blood through the aortic valve into the aorta and return to the systemic circulatory system.
- the structure of the four heart valves ensures that the valve opens when the blood is in the forward direction and closes in the opposite direction, preventing the heart burden from being aggravated by the blood backflow.
- it can lead to acquired damage or lesions of the heart valve, such as rheumatism, atherosclerosis and the like.
- congenital heart disease such as tetralogy of Fallot can also produce pulmonary valve disease in the long-term after surgery.
- Valvular lesions are characterized by a gradual loss of valve function, such as valvular insufficiency leading to blood regurgitation, narrow blood vessels leading to poor blood circulation, or a combination of dysplasia and stenosis, resulting in increased heart burden, leading to heart failure.
- the traditional treatment is to open the chest, after the heart stops, under the support of hypothermia cardiopulmonary bypass, open the heart for surgical repair of the diseased valve or replacement with artificial heart valve.
- Existing artificial heart valves fall into two broad categories: metal mechanical valves and biological valves.
- the biological valve is made of animal materials such as bovine pericardium, bovine jugular vein valve and porcine aortic valve.
- the above-mentioned method of cardiac surgery has a long operation time, high cost, large trauma, and high risk. After metal mechanical valve replacement, the patient needs long-term anticoagulant therapy, and the material life of the biological valve is limited, and usually requires surgery.
- the balloon-expandable prosthetic heart valve is a biological valve
- the intervention method is to fix the biological valve on a plastically deformable stent respectively, and after diameter is compressed on a balloon, the diameter is reduced, percutaneously implanted, and then given The balloon is pressurized to expand and fix the stent to reach the working state.
- the disadvantages and problems of this artificial valve are: The diameter is determined by the diameter of the balloon.
- the natural valve may increase, and the caliber of the prosthetic valve may not be adaptive, and the prosthetic valve may be loose or slipped, and only the secondary balloon may be re-expanded.
- the prosthetic valve is provided with an elastically deformable stent that expands radially after compression.
- the shortcomings and problems are: The friction between the self-expanding artificial heart valve and the sheath is large, which affects the accurate release of the artificial valve.
- the disadvantages and problems associated with the balloon-expandable and self-expanding prosthetic heart valves are: The expansion of the prosthetic valve is irreversible; whether it is a balloon-expandable or self-expanding prosthetic valve, the expansion of the compressed valve is an irreversible process. , the position and size can not be moved and exchanged once it is wrong. If the position of the aortic valve is misplaced, it can affect the mitral valve function in one direction and affect the blood flow to the entrance of the coronary artery in the other direction. Other prosthetic valves that are not in position will also affect the function of their own or adjacent valves. Once the size of the desired prosthetic valve is measured, the artificial heart valve that is placed will be of a different size and cannot fully guarantee the function of the valve. Once strained or not working properly due to various factors, it can only be replaced by surgery. Summary of the invention
- an interventional prosthetic heart valve comprising: a tubular mesh frame radially deformable between an expanded state and a compressed state, at least one piece joined to the inside of the tubular mesh frame
- the valve leaf that can be moved or switched is covered with a film on the inside and/or outside of the tubular grid.
- An interventional artificial heart valve implantation and recovery device comprising: a sheath tube, an open sheath tube, a recovery tube and a recovery hook, the open sheath tube is sleeved in the sheath tube, and the recovery hook sliding sleeve is disposed in the recovery tube, and is recycled The tube and the recovery hook are slid together in the open sheath.
- the prosthetic valve can be implanted by radial compression and inserted into the method.
- the function of the prosthetic valve after expansion and release is the same as that of the happy surgical valve.
- the shape, structure and function of the prosthetic valve are optimized in the following aspects:
- the shape of the stent of the existing artificial valve is a circular tube shape
- the shape of the stent of the artificial valve is a spherical shell shape on the sides of the circular tube, and the diameter of the spherical shell is larger than the diameter of the distal and proximal ends.
- it conforms to the anatomy of the aortic root and is easy to locate upstream and downstream, and on the other hand prevents the artificial valve from slipping (the diameter of the spherical shell segment is larger than the diameter of the distal and proximal ends of the aortic vessel).
- the existing prosthetic valve in aortic valve replacement, is either very short (about 14mm balloon expansion type), positioning requires that the upstream end is less than the mitral valve, the downstream end does not block the left and right coronary artery opening, which makes the actual operation difficult And because of the short axial instability, it is easy to tilt; it is very long (self-expanding type), and its downstream end exceeds the aortic bulb root, which may affect the left and right coronary blood supply.
- the aortic valve prosthetic heart valve is longer than Henning Rud ANDERSEN and Alain Cribier, and has good axial stability and is not easy to tilt.
- the biological valve leaf and the synthetic valve leaf can be sewn on the deformable stent to work.
- Synthetic valve leaflets increase the source of the valve, product stability and safety.
- the valve leaf of the prosthetic valve is a synthetic valve leaf strengthened by fiber reinforcement, and the fiber strengthens the synthetic valve leaf in the selected direction, as in the valve leaf switch direction, in the valve Joint point, at the edge of the valve.
- Each individual leaflet can be reinforced with fiber reinforcement alone or with multiple valve leaflets and fiber reinforcement.
- the artificial valve After the artificial valve is implanted, the artificial valve that can not work normally after reaching a certain life span can only be retrieved by surgical methods. And part of the prosthetic valve has a receiving frame on the bracket, and put The recovery hook of the receiving device can be used to compress the implanted valve radially by an interventional method, and then can be taken out, and can be re-inserted.
- the surgically implanted prosthetic valve, the biological valve fixed on the non-deformation bracket can not work normally after aging, and the insufficiency after hardening or damage can only be retrieved by surgical methods.
- a new artificial valve can be implanted on the original prosthetic valve by an interventional method.
- the shape of the stent of the artificial valve of the specific design is the same as that of the circular cylinder on both sides of the cylinder, and the diameter of the circular table on both sides is larger than the diameter of the central cylinder.
- the prosthetic valve made of the stent can be radially compressed and then input by an interventional method to expand and release on the original prosthetic valve.
- the round table on both sides of the expanded prosthetic valve is caught by the non-deformation bracket of the biological valve.
- Round tables on both sides, at least the downstream round table can be equipped with anti-slip barbs.
- the downstream round table can also be equipped with a recycling rack.
- the function of the implant device is optimized in the following aspects:
- Expansion of a compressed prosthetic heart valve is a controlled process: (a) The rate of expansion of the compressed prosthetic heart valve can be controlled by tensioning the pull wire or by controlling the relative position between the open sheath and the sheath. The speed is generally slower than the balloon-expandable type, and can be reversed. It can also be properly positionally adjusted during the expansion process, so the position of the prosthetic valve after expansion is more accurate.
- the pull wires can be separately controlled, and the compressed artificial valves are sequentially expanded; the control can also be performed in a unified manner, and the compressed artificial valves are expanded in parallel. Prosthetic valves that expand in parallel during expansion are less obstructive to blood flow. Because the resistance is small, the positioning is more accurate.
- the prosthetic valve is expanded and finally released (separated from the implant device:) with the help of a special locking wire for its implant device. Two steps after one.
- the expanded prosthetic valve can be recompressed, moved, and expanded. After the position and valve function are checked, the prosthetic valve is irreversibly separated from the implant (final release).
- the implant device assists in the accurate delivery and rotation of the aortic valve prosthetic heart valve.
- the curvature of the positioning section of the delivery tube is in agreement with the curvature of the aortic arch.
- the second guide wire can be used to enter the left and right coronary arteries by means of a thin guide wire opening of the working section of the delivery tube. Bit.
- a self-expanding valve compressed by a round sheath tube alone cannot be used for coronary artery entrance positioning.
- the function of the implant and recovery device is optimized in the following aspects compared to existing implant devices for self-expanding prosthetic valves:
- the fistula sheath is between the prosthetic heart valve and the sheath.
- the compressed prosthetic heart valve in particular the prosthetic heart valve with an anti-slip bark on the outer surface, is separated from the sheath by means of an open sheath, without contact and friction with the sheath.
- the friction between the open sheath and the compressed artificial heart valve is large, and there is no sliding, which ensures that the artificial heart valve (with or without anti-slip barb) is not damaged during implantation;
- the open sheath can be The choice of high slidability materials such as PTFE and PE ensures low friction sliding between the open sheath and the sheath.
- the fistula sheath is also used to recover the prosthetic valve by intervention. Its flared opening helps the radial compression of the prosthetic valve. The process of entering the sheath is only the contact between the prosthetic valve and the open sheath (no friction) and the sliding between the open sheath and the sheath without the contact between the prosthetic valve and the sheath.
- the membrane on the artificial valve metal stent whether biological or synthetic, has the following advantages:
- the film can prevent blood leakage around the artificial valve.
- the non-recyclable prosthetic valve of the present invention has anti-slip barb on the outer circumference, and the valve can be prevented from moving under the influence of blood flow after being inserted into the blood vessel wall.
- a retractable artificial heart valve has a receiving frame on the bracket;
- the surface of the retrievable prosthetic heart valve (valve leaf and lamella) is covered by synthetic material, and no vascular endothelial cells grow into the prosthetic valve, which is easy to remove by interventional methods;
- Recyclable prosthetic heart valve implantation and recovery device has a recovery hook; 8.4.
- the implantable and recovery device for the retrievable prosthetic heart valve has an open sheath.
- FIG. 4 is a schematic structural view of a first embodiment of an interventional artificial heart valve according to the present invention (non-recoverable artificial pulmonary valve), wherein FIG. 1 is a schematic structural view in an expanded state, FIG. 2 3 is a right side view of FIG. 1, wherein FIG. 3 is a valve leaf in an open state, and FIG. 4 is a valve leaf in a closed state;
- FIG. 5 to FIG. 7 are schematic structural views of a second embodiment (non-recoverable artificial aortic valve) of the interventional artificial heart valve of the present invention, wherein FIG. 5 is a schematic structural view in an expanded state, and FIG. 6 is a compressed state.
- Figure 7 is a cross-sectional view taken along line AA of Figure 5;
- FIGS. 8 to FIG. 11 are structural diagrams of a third embodiment (recoverable artificial pulmonary valve) of the interventional artificial heart valve of the present invention, wherein FIGS. 8 and 9 are schematic views of the structure in an expanded state (FIG. 9 not all)
- Figure 10 is a right side view of Figure 8
- Figure 11 is a cross-sectional view taken along line BB of Figure 10
- Figure 12 - Figure 16 is a fourth embodiment of an interventional prosthetic heart valve of the present invention (recyclable artificial main)
- Schematic diagram of the arterial valve wherein Fig. 12 is a schematic view of the structure in a compressed state, Figs. 13 and 14 are schematic views of the structure in an expanded state (Fig. 14 does not show a film), and Fig. 15 is a right side view of Fig. 13, Fig. 16 a cross-sectional view taken along line CC of FIG. 13;
- FIG. 17 to FIG. 19 are schematic views showing the structure of a fifth embodiment of an invasive prosthetic heart valve according to the present invention (a non-recoverable sacral artificial heart valve), wherein FIG. 17 is a schematic structural view in a compressed state, and FIG. 18 is an expanded state. 19 is a radial cross-sectional view of FIG. 18;
- FIG. 20 to FIG. 21 are schematic views showing the structure of a sixth embodiment of an invasive prosthetic heart valve according to the present invention (recoverable sacral prosthetic heart valve), wherein FIG. 20 is a structural view in a compressed state, and FIG. 21 is an expanded state. Schematic diagram of the structure;
- FIG. 22 to FIG. 24 are schematic views showing the structure of a seventh embodiment of the interventional artificial heart valve of the present invention (non-recyclable artificial aortic valve), wherein FIG. 22 is a schematic view of the structure, and FIG. 23 is a schematic view of the aortic root.
- Schematic diagram of a radial cross-sectional view; Figure 24 is a schematic axial cross-sectional view of the aortic root; 25 to FIG. 27 are schematic views showing the structure of an eighth embodiment of an interventional artificial heart valve (recoverable artificial aortic valve) according to the present invention, wherein FIG. 25 is a schematic view of the structure, and FIG. 26 is a schematic view of the aortic root.
- Figure 27 is a schematic axial cross-sectional view of the aortic root;
- FIG. 28 is a schematic structural view of an implantable prosthetic heart valve implant device according to the present invention
- FIG. 29 is a schematic structural view of the implanted device working segment assembled with a prosthetic heart valve in a compressed state
- Figure 30 is a schematic view showing the structure of the artificial heart valve in the working section of the implant device according to the present invention and in an expanded state;
- Figure 31 is a schematic view showing the overall structure of an implantable artificial heart valve implantation and recovery device of the present invention.
- Figure 32 is a schematic view showing the combined structure of the recovery tube and the recovery hook in the implantation and recovery device;
- Figure 33 is a schematic view showing the combined structure of the sheath tube and the open sheath tube in the implantation and recovery device;
- Figure 34 - Figure 37 is the present invention A schematic diagram of the working process of an implantable prosthetic heart valve implantation and recovery device for implanting or retrieving an interventional prosthetic heart valve; wherein Figure 34 is a delivery rack for the implantation and recovery device with a recovery hook hooking the prosthetic heart valve.
- Figure 35 shows the insertion of the prosthetic heart valve into the implantation and recovery device.
- Figure 36 shows the open sheath of the prosthetic heart valve into the implantation and recovery device.
- Figure 37 shows the sheath in the implantation and recovery device. The open sheath, the prosthetic heart valve is compressed and enters the sheath with the open sheath.
- the structure of the interventional prosthetic heart valve of the present invention can be further described by the following examples.
- FIG. 1 to FIG. 4 are schematic structural views of a first embodiment of an interventional artificial heart valve according to the present invention, wherein FIG. 1 is a schematic view of the structure in an expanded state.
- Figure 2 is a schematic view of the structure in a compressed state
- Figures 3 and 4 are right side views of Figure 1, wherein Figure 3 shows the valve leaf in an open state (the free edge phase separation of each valve leaf), and Figure 4 shows the valve.
- the leaves are in a closed state (the free edges of each valve leaf are in contact).
- the non-recyclable artificial pulmonary valve 1 of the present embodiment includes a tubular mesh frame 11, a valve leaf 12 and a membrane 13.
- the tubular grid 11 is made of an elastic or plastically deformable material and has a circular tube shape of uniform size; the valve leaf 12 and the membrane 13 are made of a biological material and are sewn to the stent.
- 111 is a deformable unit
- 112 is a joint ring
- 121 is a joint line
- 122 is a joint point
- 123 is a movable leaflet.
- FIG. 5 - FIG. 7 is a schematic structural view of a second embodiment of the interventional artificial heart valve of the present invention, wherein FIG. 5 is a structure in an expanded state
- FIG. 6 is a schematic structural view in a compressed state
- FIG. 7 is a cross-sectional view taken along line AA of FIG. 5.
- the non-recyclable artificial aortic valve 2 of the present embodiment includes a tubular mesh 21 made of an elastically deformable material, a valve leaf 22 made of a biomaterial, and a film 23 made of a synthetic material.
- the tubular mesh frame 21 has a circular tube shape of uniform size, and three openings 215 are provided in the tubular mesh frame 21 to fit the coronary artery and have barbs 216.
- the anti-slip barb 216 and the longitudinal axis of the bracket are at an angle of 30-90 degrees, the opening direction is toward the middle of the bracket, and the anti-skid barb at the downstream end is opposite to the anti-slip barb opening at the upstream end.
- non-slip barbs are also compressed and parallel to the longitudinal axis of the stent under compression. Due to the shortened length of the compression stent during expansion, these opposite anti-slip barbs are more convenient for piercing the blood vessel. These two opposite anti-slip barbs ensure stability in both directions, ie, the direction of reverse blood flow and the direction of blood flow. At least one row of downstream end anti-slip barbs is required in the actual production to ensure that the stent does not move in the countercurrent direction when the valve is closed.
- 211 is a deformable unit
- 212 is a bond ring
- 214 is a tracer ring.
- 221 is the combined line
- 222 is the joint point
- 223 is the active leaflet
- 226 is the free edge of the valve leaf 22.
- FIG. 8-11 is a schematic structural view of a third embodiment of the interventional artificial heart valve of the present invention, wherein FIG. 8 and FIG. 9 are in an expanded state.
- FIG. 10 is a right side view of FIG. 8
- FIG. 11 is a cross-sectional view taken along line BB of FIG.
- the retrievable artificial pulmonary valve 3 of the present embodiment comprises a tubular mesh frame 31 made of an elastically deformable material, a valve leaf 32 made of a synthetic material, and a film 33 made of a synthetic material.
- the tubular grid 31 has a circular tube shape of uniform size, and has a receiving frame 313 at its proximal end for cooperation with the implant device. Function. As shown in the figure, 31 1 is a deformable unit and 312 is a joint ring. 321 is the combined line, 322 is the joint point, 323 is the active leaflet, 325 is the reinforcing fiber for a single independent leaflet reinforcement, and 326 is the free edge of the valve leaf 32.
- FIG. 12 to FIG. 16 are schematic structural views of a fourth embodiment of the interventional artificial heart valve according to the present invention, wherein FIG. 12 is a structure in a compressed state.
- Fig. 13 and Fig. 14 are schematic views showing the structure in an expanded state (Fig. 14 does not show a film)
- Fig. 15 is a right side view of Fig. 13
- Fig. 16 is a cross-sectional view taken along line CC of Fig. 13. '
- the retrievable artificial aortic valve 4 of the present embodiment comprises a tubular mesh frame 41 made of an elastically deformable material, a valve leaf 42 made of a synthetic material, and a film 43 made of a synthetic material.
- the tubular mesh frame 41 has a circular tube shape of uniform size, and three openings 415 are provided on the tubular mesh frame 41 to fit the coronary artery, and a loading frame 413 is provided at the proximal end thereof for cooperation with the implant device. effect.
- the valve leaf 42 and the reinforcing fiber 425 and the coating 43 in this embodiment are integrally formed on the tubular mesh frame 41 to realize integration and seamless integration, and the corner joints, the lines and the adjacent faces are rounded.
- 411 is a deformable unit and 412 is a bond ring.
- 421 is the joint line
- 422 is the joint point
- 423 is the active leaflet
- 425 is the reinforcing fiber for the multi-valve leaf and reinforcement
- 426 is the free edge of the valve leaf 42.
- FIGS. 17-19, FIG. 17 to FIG. 19 are schematic structural views of a fifth embodiment of the interventional prosthetic heart valve according to the present invention, wherein FIG. 17 is in a compressed state.
- FIG. 18 is a schematic structural view in an expanded state, and
- FIG. 19 is a radial cross-sectional view of FIG. 18.
- the non-recoverable sickle prosthetic heart valve 5 of the present embodiment is used for replacing the implanted surgical artificial biological valve 01, which comprises a rigid support ring 011, a rigid support column 012 and a biological valve leaf 013.
- the tubular mesh frame 51 of the non-recoverable ⁇ -shaped prosthetic heart valve 5 of the present embodiment has a shape of a circular tube 517 at the middle and a circular shape of a circular table 518 at both ends, and the diameter of the circular table at both ends is larger than the diameter of the central circular tube.
- 52 is the valve leaf
- 53 is the membrane
- 512 is the binding ring
- 514 is the inverted.
- 523 is the active leaflet and 525 is the reinforcing fiber.
- FIG. 20 is a schematic structural view of a sixth embodiment of the interventional prosthetic heart valve according to the present invention, wherein FIG. 20 is in a compressed state.
- Schematic diagram of the structure Fig. 21 is a schematic view of the structure in an expanded state.
- the retrievable sickle prosthetic heart valve 6 of the present embodiment is used to replace the implanted surgical artificial biological valve 01, which comprises a rigid support ring 011, a rigid support column 012 and a biological valve leaf 0 .
- the tubular mesh frame 61 of the retrievable sacral prosthetic heart valve 6 of the present embodiment has a shape of a circular tube 617 in the middle and a circular shape in the middle of the circular table 618. The diameter of the circular table at both ends is larger than the diameter of the central circular tube.
- 62 is a valve leaf
- 63 is a film
- 612 is a binding ring
- 613 is a discharge frame.
- 623 is the active leaflet and 625 is the reinforcing fiber.
- FIG. 22 is a schematic structural view of a seventh embodiment of the interventional artificial heart valve according to the present invention, wherein FIG. 22 is a schematic structural view thereof.
- 23 is a schematic view of a radial cross-sectional view of the aortic root;
- FIG. 24 is a schematic axial cross-sectional view of the aortic root.
- the non-recyclable artificial aortic valve 7, of this embodiment is used to implant the root of the aorta 02, which includes natural coronary openings 021 and 022.
- 023 represents the downstream end of the native aortic valve
- 024 represents the upstream end of the native aortic valve.
- the tubular net frame 71 of the non-recoverable artificial aortic valve 7 of the present embodiment has a shape of a spherical tube having a central portion of a spherical shell 719 and a rounded tube 717 at both ends, and the diameter of the central spherical shell is larger than that of the two ends.
- Diameter 2-3 openings 715 are provided in the central spherical shell, the 2-3 openings being distributed radially along the tubular grid and larger than other deformable units on the tubular grid.
- 72 is the valve leaf
- 73 is the coating
- 712 is the binding ring
- 716 is the inverted.
- 721 is the union line
- 722 is the joint point
- 723 is the active leaflet
- 725 is the reinforcing fiber
- 726 is the free edge of the active leaflet.
- FIG. 25 to FIG. 27 are schematic structural diagrams of an eighth embodiment of an interventional artificial heart valve according to the present invention, wherein FIG. 25 is a schematic structural view thereof.
- 26 Schematic diagram of a radial cross-sectional view of the aortic root;
- Figure 27 is a schematic axial cross-sectional view of the aortic root.
- the retrievable artificial aortic valve 8 of the embodiment is used for implanting the root of the aorta 02,
- the aorta 02 includes natural coronary openings 021 and 022.
- 023 represents the downstream end of the native aortic valve
- 024 represents the upstream end of the native aortic valve.
- the tubular mesh frame 81 of the retrievable artificial aortic valve 8 of the present embodiment has an expanded shape and a spherical shape of a spherical shell 819 at the middle and a round tube 817 at both ends, and the diameter of the central spherical shell is larger than that of the two ends.
- Diameter; 2-3 openings 815 are provided in the central spherical shell, the 2-3 openings being distributed radially along the tubular grid and larger than other deformable units on the tubular grid.
- 82 is a valve leaf
- 83 is a film
- 812 is a binding ring
- 813 is a receiving frame.
- 821 is the joint line
- 822 is the joint point
- 823 is the active leaflet
- 825 is the reinforcing fiber
- S26 is the free edge of the active leaflet.
- FIG. 28 is a schematic structural view of an implantable prosthetic heart valve implant device according to the present invention
- FIG. 29 is a schematic structural view of the implanted device working segment assembled with a prosthetic heart valve in a compressed state
- the implantable prosthetic heart valve implant device 9 of the present invention comprises a delivery tube 91, at least one locking wire 92, at least one pull wire 93, at least one guide wire 94, at least one wire fixing plug 95 and a lock. Wire fixation plug 96.
- the conveying pipe 91 is composed of a polymer material and a high elastic metal reinforcing mesh, wherein the high elastic metal reinforcing mesh is composed of a highly elastic alloy wire.
- the conveying pipe 91 includes a front end working section 911, a semi-circular arc positioning section 912, and a conveying section 913 which are integrally connected in series. At least one distal wire opening 91 1 1 (three in this embodiment) and at least one thin wire mesh opening 91 12 (two in this embodiment) are provided on the front working section 911 from front to back. At least one proximal pull wire opening 9113 (one in this embodiment), the distance between the distal pull wire opening 9111 and the proximal pull wire opening 9113 is slightly greater than the length of the compressed artificial heart valve.
- the thin guide wire opening 9112 is used for the passage of a 0.014" diameter coronary guide wire.
- the port at the front end working section can also be connected to a tapered catheter 97 which is made of a very soft material to prevent damage to the vessel wall. And the natural valve, the length depends on the need.
- the tapered catheter tip is provided with a guide wire opening 971 for the guide wire of 0.030" and 0.035" diameter.
- the semi-circular positioning segment 912 is prefabricated, when When inserted into a blood vessel, it is straightened under an external force.
- the locking wire 92 is an elastic steel wire which penetrates the conveying pipe, and may also be a hollow elastic pipe.
- One end of the pull wire 93 is provided with a wire loop 931.
- the wire ends 932 of the respective wire extensions respectively extend from the wire branch pipes at the rear end of the conveying pipe, and are fixed by the wire fixing bolts 95.
- the wire loops 931 of the wire wires respectively extend from the distal wire opening 9111 or the proximal wire opening 9113 of the working end of the pipe. Out. During operation, the wire loops 931 from the wire opening respectively bypass the tubular grid or the artificial heart valve, and then return to the same or adjacent distal wire opening 91 11 or the proximal wire opening 9113, respectively, and are threaded by the locking wire 92. Overlocked.
- Each of the guide wires 94 and the locking wire 92 protrudes from the front end of the conveying pipe through the conveying pipe, and the wire fixing bolt 95 can be screwed on the nozzle of the wire drawing pipe for fixing the wire, and the locking wire fixing bolt 96 can be screwed on the conveying pipe.
- the rear port 9131 is used to fix the locking wire.
- the non-recyclable prosthetic heart valve is placed concentrically in the working section of the delivery tube of the implant device, with the prosthetic heart valve outside and the delivery tube.
- the upstream and downstream ends of the prosthetic heart valve are not the same as the orientation of the implant:
- Reverse blood inflow The upstream end of the prosthetic heart valve coincides with the anterior end of the working section of the delivery tube of the implant device.
- the downstream end of the prosthetic heart valve coincides with the anterior end of the working section of the delivery tube of the implant device.
- the pull wire exits from the distal wire opening and the proximal wire opening of the delivery tube, shuttles around the coupling ring of the artificial heart valve and then returns to the same or adjacent wire opening, and the wire loop of the wire is passed through by the locking wire.
- Each pull wire is controlled by a wire fixing bolt provided on the wire branch pipe. It can be controlled individually or in combination and unified.
- One or more middle wire drawing ports may be provided between the distal wire opening and the proximal wire opening, but the pulling wire does not have to repeatedly shuttle in the bracket.
- Prosthetic heart valve compression The thread ends of the pull-up cable, the tension of the cable is increased, the prosthetic valve is compressed radially, and the axial direction is slightly elongated.
- the wire fixing bolt can fix the wire to the wire branch pipe.
- the diameter of 0,030" or 0,035" can be made from the thick guide wire on the tip of the tapered catheter, from the end of the delivery tube, through the delivery tube of the implant device. . If a prosthetic prosthetic valve with a coronary opening is used, 1-2 diameter 0,014" guidewires can be used to access the thin guidewire opening of the implant device for rotational guidance prior to insertion into the vessel. After insertion: The curvature of the positioning segment of the delivery tube coincides with the curvature of the aortic arch.
- Prosthetic valve dilatation In general, the natural diseased valve does not move, and the prosthetic valve is implanted in situ on the diseased valve, or downstream of the natural pulmonary valve or natural aortic valve. After the compressed artificial valve is in place, the wire fixing bolt on the wire branch pipe is released, the tension of the wire is lowered, and the artificial valve is expanded under its own elastic force.
- the proximal and distal ends of the prosthetic valve can be simultaneously expanded.
- the proximal end and the distal end may also be expanded at different times.
- the expansion of the spherical shell in the middle of the prosthetic valve can achieve the upstream and downstream positioning, and then the upstream and downstream ends are expanded again.
- the expanded prosthetic valve has less obstruction to blood flow during the expansion process.
- the locking wire is withdrawn, the wire loop lock of the wire is released, and the bond between the prosthetic valve and the implant device is eventually irreversibly released.
- FIG. 31 is a schematic view showing the overall structure of the implantation and recovery device for the interventional artificial heart valve of the present invention
- Figure 32 is a schematic view showing the combined structure of the recovery tube and the recovery hook in the implantation and recovery device
- the implantable prosthetic heart valve implantation and recovery device 10 of the present invention comprises a sheath 101, an open sheath 102, a recovery tube 103 and a recovery hook 104.
- the open sheath 102 is slidably fitted in the sheath 101, and the recovery hook 104
- the sliding set is placed in the recovery tube 103, and the recovery tube and the recovery hook are slid together in the open sheath.
- the sheath 101 includes a forward straight section 1011 and a rear flared section 1012, the flared section having an inner diameter greater than the inner diameter of the straight section.
- the open sheath tube 102 includes a front end opening section 1021 and a rear end straight tube section 1022.
- the opening section 1021 is made of two or more lobes cut from the front end of the straight tube section, and can be contracted and slid into the sheath tube.
- the recovery pipe 103 is a straight pipe.
- the recovery hook 104 is composed of a long rod 1041 and a grapple 1042 attached to the front end of the long rod.
- the grapple is composed of three curved grippers, one of which is longer than the other two curved grippers and has The hook 10422, the grapple can be contracted and slid into the recovery tube.
- the three curved grippers are 120 degrees apart from each other, and are flared in a natural state, and the diameter after opening is larger than the diameter of the recovery pipe.
- the working principle of the implantable prosthetic heart valve implantation and recovery device for implanting the artificial heart valve of the present invention can be illustrated as follows with reference to Figs. 34-37:
- the retracting hook of the prosthetic heart valve is hooked by the implantation and recovery device with the recovery hook 104, and then the recovery tube 103 is advanced to make the three of the grapple 1042
- the curved gripper and the hook in the elastic deformation are equally close to the center, and the hook is locked, and the retractable artificial heart valve can not be disengaged, forming a state as shown in FIG.
- the entire retractable prosthetic heart valve is then placed in the flare of the open section 1021 of the open sheath 102 to form a state as shown in FIG.
- the sheath 101 is then pressed into the forward end to compress the open sheath 102 and the prosthetic heart valve therein from semi-compressed to fully compressed. All of them enter the sheath 101, and a state as shown in Fig. 37 is formed.
- the entire device can then be inserted into the blood vessel and moved toward the natural valve. Once moved into position, the sheath 101 can be gradually withdrawn, causing the fistula sheath 102 and the prosthetic valve to gradually expand from compression to semi-expansion to full expansion. Then, the open sheath 102 is withdrawn.
- the recovery tube 103 is slightly withdrawn, the lock between the release rack on the artificial valve and the recovery hook 104 is released, and the recovery hook 104 is finally withdrawn. That is, the implantation process of the artificial valve is completed.
- the implantation and recovery device of the interventional artificial heart valve of the present invention for the recovery process of the artificial valve can be briefly described as follows:
- Retracting hooks on the hooks 104 are attached to the ejector on the prosthetic heart valve;
- the recovery pipe 103 slides toward the return hook so that the grapple 1042 and the return hook therein are equally close to the center, and the return hook is locked, and the release frame on the artificial heart valve cannot be free;
- the sheath 101 is slid in the direction of the prosthetic valve to radially compress the open sheath 102 and the prosthetic valve; the sheath 101 and the compressed valve therein are recovered.
- the interventional prosthetic heart valve of the invention and the implantation and recovery device thereof are mainly used for human aortic and pulmonary valve replacement.
- the invention makes the heart valve replacement surgery without the need of opening the chest, without extracorporeal circulation, without the need for general anesthesia.
- the heart beats the valve, and the patient does not need long-term anticoagulation.
- the inserted valve can be removed by percutaneous intervention for valve replacement.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410054347 CN1745727A (zh) | 2004-09-08 | 2004-09-08 | 介入式人工心脏瓣膜及其植入和回收装置 |
CN200410054347.0 | 2004-09-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006026912A1 true WO2006026912A1 (en) | 2006-03-16 |
Family
ID=36036069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2005/001398 WO2006026912A1 (en) | 2004-09-08 | 2005-09-05 | An implantable artificial heart valve and implanting and retracting device |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN1745727A (zh) |
WO (1) | WO2006026912A1 (zh) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8133270B2 (en) | 2007-01-08 | 2012-03-13 | California Institute Of Technology | In-situ formation of a valve |
US8414641B2 (en) | 2007-12-21 | 2013-04-09 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
US8460365B2 (en) | 2005-09-21 | 2013-06-11 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US8470023B2 (en) | 2007-02-05 | 2013-06-25 | Boston Scientific Scimed, Inc. | Percutaneous valve, system, and method |
US8721717B2 (en) | 2003-12-19 | 2014-05-13 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US8932349B2 (en) | 2004-09-02 | 2015-01-13 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US9028542B2 (en) | 2005-06-10 | 2015-05-12 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
US9301843B2 (en) | 2003-12-19 | 2016-04-05 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US9370419B2 (en) | 2005-02-23 | 2016-06-21 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US9622859B2 (en) | 2005-02-01 | 2017-04-18 | Boston Scientific Scimed, Inc. | Filter system and method |
US9668859B2 (en) | 2011-08-05 | 2017-06-06 | California Institute Of Technology | Percutaneous heart valve delivery systems |
US9744037B2 (en) | 2013-03-15 | 2017-08-29 | California Institute Of Technology | Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves |
CN107157621A (zh) * | 2016-09-23 | 2017-09-15 | 杭州启明医疗器械有限公司 | 一种可回收及重复定位介入器械的输送系统 |
US9861473B2 (en) | 2005-04-15 | 2018-01-09 | Boston Scientific Scimed Inc. | Valve apparatus, system and method |
CN108371570A (zh) * | 2017-10-24 | 2018-08-07 | 杭州启明医疗器械有限公司 | 一种操作稳定的介入心脏瓣膜可回收输送系统 |
CN108670501A (zh) * | 2018-05-07 | 2018-10-19 | 杭州启明医疗器械有限公司 | 一种便于回收介入器械的鞘管以及输送系统 |
CN109419571A (zh) * | 2017-08-25 | 2019-03-05 | 上海微创心通医疗科技有限公司 | 自膨胀假体的输送装置及自膨胀心脏瓣膜假体的输送装置 |
EP3492043A3 (en) * | 2007-08-21 | 2019-09-04 | Symetis SA | A replacement valve |
EP2387973B1 (en) | 2006-09-07 | 2020-11-25 | Symetis SA | Stent-valve delivery system |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005003632A1 (de) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Katheter für die transvaskuläre Implantation von Herzklappenprothesen |
CN101045023B (zh) * | 2006-03-30 | 2011-04-13 | 温宁 | 自扩型支架收线压紧机构 |
FR2906998B1 (fr) * | 2006-10-16 | 2009-04-10 | Perouse Soc Par Actions Simpli | Implant destine a etre place dans un conduit de circulation du sang. |
CN101172058B (zh) * | 2006-10-31 | 2011-04-06 | 温宁 | 支架与生物瓣膜编织成一体的支架瓣膜及其制作方法 |
CN101172059B (zh) * | 2006-10-31 | 2010-12-08 | 温宁 | 带内层舌状结构的支架瓣膜及其支架的编织方法 |
EP1980220A1 (en) * | 2007-04-13 | 2008-10-15 | JenaValve Technology GmbH | Medical device for treating a heart valve insufficiency or stenosis |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
ES2903231T3 (es) | 2008-02-26 | 2022-03-31 | Jenavalve Tech Inc | Stent para el posicionamiento y anclaje de una prótesis valvular en un sitio de implantación en el corazón de un paciente |
CN101601611B (zh) * | 2009-04-03 | 2012-02-01 | 中国人民解放军第二军医大学 | 微创手术下反复置换的装配式人造心脏生物瓣膜治疗装置 |
AU2010295291B2 (en) * | 2009-09-21 | 2013-10-24 | Medtronic Inc. | Stented transcatheter prosthetic heart valve delivery system and method |
US8652203B2 (en) | 2010-09-23 | 2014-02-18 | Cardiaq Valve Technologies, Inc. | Replacement heart valves, delivery devices and methods |
CN101961269B (zh) * | 2010-04-19 | 2012-09-05 | 杭州启明医疗器械有限公司 | 用于输送人造瓣膜置换装置的输送装置 |
BR112012029896A2 (pt) | 2010-05-25 | 2017-06-20 | Jenavalve Tech Inc | válcula cardíaca protética para endoprótese e endoprótese |
JP6005168B2 (ja) | 2011-10-21 | 2016-10-12 | イエナバルブ テクノロジー インク | 患者の身体への拡張型心臓弁ステント導入用カテーテルシステム、カテーテルシステムを備えた挿入システムおよび心臓弁欠陥治療用医療機器 |
WO2013171007A1 (en) | 2012-05-16 | 2013-11-21 | Jenavalve Technology Gmbh | Catheter delivery system for introducing an expandable heart valve prosthesis and medical device for the treatment of a heart valve defect |
CN102670332B (zh) * | 2012-05-24 | 2016-08-03 | 沛嘉医疗科技(上海)有限公司 | 一种新型的人工心脏瓣 |
US9445797B2 (en) * | 2012-09-13 | 2016-09-20 | Medtronic, Inc. | Percutaneous atrial and ventricular septal defect closure device |
CN105491978A (zh) | 2013-08-30 | 2016-04-13 | 耶拿阀门科技股份有限公司 | 用于假体瓣膜的径向可折叠框架及其制造方法 |
CN104257444A (zh) * | 2014-10-17 | 2015-01-07 | 黄景陶 | 可中途回收的人体管腔支架置入器 |
CN104771249B (zh) * | 2015-04-20 | 2018-09-21 | 上海纽脉医疗科技有限公司 | 一种介入式人工心脏瓣膜及其制备方法 |
CN104758092B (zh) * | 2015-04-20 | 2018-09-18 | 上海纽脉医疗科技有限公司 | 一种介入式人工心脏瓣膜输送系统 |
EP3288495B1 (en) | 2015-05-01 | 2019-09-25 | JenaValve Technology, Inc. | Device with reduced pacemaker rate in heart valve replacement |
US11065138B2 (en) | 2016-05-13 | 2021-07-20 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
WO2018138658A1 (en) | 2017-01-27 | 2018-08-02 | Jenavalve Technology, Inc. | Heart valve mimicry |
CN109745148A (zh) * | 2017-11-03 | 2019-05-14 | 杭州启明医疗器械股份有限公司 | 介入器械输送装置 |
CN117481869A (zh) | 2018-01-25 | 2024-02-02 | 爱德华兹生命科学公司 | 在部署后用于辅助置换瓣膜重新捕获和重新定位的递送系统 |
CN108703823A (zh) * | 2018-07-27 | 2018-10-26 | 武汉开阖同立医疗科技有限公司 | 一种介入式充气型球囊主动脉瓣膜支架系统 |
CN112789009B (zh) * | 2018-10-05 | 2024-07-02 | W.L.戈尔及同仁股份有限公司 | 用于选择性展开的约束机构及相关联的方法 |
CN109938879A (zh) * | 2019-03-19 | 2019-06-28 | 上海欣吉特生物科技有限公司 | 一种手术瓣膜及其植入装置 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5855601A (en) * | 1996-06-21 | 1999-01-05 | The Trustees Of Columbia University In The City Of New York | Artificial heart valve and method and device for implanting the same |
CN1228295A (zh) * | 1999-01-21 | 1999-09-15 | 南方医院 | 编织材料人工心脏瓣膜 |
WO2002036048A1 (fr) * | 2000-10-31 | 2002-05-10 | Jacques Seguin | Support tubulaire de mise en place, par voie percutanee, d'une valve cardiaque de remplacement |
US6425916B1 (en) * | 1999-02-10 | 2002-07-30 | Michi E. Garrison | Methods and devices for implanting cardiac valves |
US20030225447A1 (en) * | 2002-05-10 | 2003-12-04 | Majercak David Christopher | Method of making a medical device having a thin wall tubular membrane over a structural frame |
-
2004
- 2004-09-08 CN CN 200410054347 patent/CN1745727A/zh active Pending
-
2005
- 2005-09-05 WO PCT/CN2005/001398 patent/WO2006026912A1/zh active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5855601A (en) * | 1996-06-21 | 1999-01-05 | The Trustees Of Columbia University In The City Of New York | Artificial heart valve and method and device for implanting the same |
CN1228295A (zh) * | 1999-01-21 | 1999-09-15 | 南方医院 | 编织材料人工心脏瓣膜 |
US6425916B1 (en) * | 1999-02-10 | 2002-07-30 | Michi E. Garrison | Methods and devices for implanting cardiac valves |
WO2002036048A1 (fr) * | 2000-10-31 | 2002-05-10 | Jacques Seguin | Support tubulaire de mise en place, par voie percutanee, d'une valve cardiaque de remplacement |
US20030225447A1 (en) * | 2002-05-10 | 2003-12-04 | Majercak David Christopher | Method of making a medical device having a thin wall tubular membrane over a structural frame |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8721717B2 (en) | 2003-12-19 | 2014-05-13 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US10869764B2 (en) | 2003-12-19 | 2020-12-22 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US9301843B2 (en) | 2003-12-19 | 2016-04-05 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US9918834B2 (en) | 2004-09-02 | 2018-03-20 | Boston Scientific Scimed, Inc. | Cardiac valve, system and method |
US8932349B2 (en) | 2004-09-02 | 2015-01-13 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US9622859B2 (en) | 2005-02-01 | 2017-04-18 | Boston Scientific Scimed, Inc. | Filter system and method |
US9370419B2 (en) | 2005-02-23 | 2016-06-21 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US9808341B2 (en) | 2005-02-23 | 2017-11-07 | Boston Scientific Scimed Inc. | Valve apparatus, system and method |
US9861473B2 (en) | 2005-04-15 | 2018-01-09 | Boston Scientific Scimed Inc. | Valve apparatus, system and method |
US9028542B2 (en) | 2005-06-10 | 2015-05-12 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
US11337812B2 (en) | 2005-06-10 | 2022-05-24 | Boston Scientific Scimed, Inc. | Venous valve, system and method |
US8672997B2 (en) | 2005-09-21 | 2014-03-18 | Boston Scientific Scimed, Inc. | Valve with sinus |
US10548734B2 (en) | 2005-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US9474609B2 (en) | 2005-09-21 | 2016-10-25 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US8460365B2 (en) | 2005-09-21 | 2013-06-11 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
EP2387973B1 (en) | 2006-09-07 | 2020-11-25 | Symetis SA | Stent-valve delivery system |
US8348999B2 (en) | 2007-01-08 | 2013-01-08 | California Institute Of Technology | In-situ formation of a valve |
US8133270B2 (en) | 2007-01-08 | 2012-03-13 | California Institute Of Technology | In-situ formation of a valve |
US11504239B2 (en) | 2007-02-05 | 2022-11-22 | Boston Scientific Scimed, Inc. | Percutaneous valve, system and method |
US9421083B2 (en) | 2007-02-05 | 2016-08-23 | Boston Scientific Scimed Inc. | Percutaneous valve, system and method |
US10226344B2 (en) | 2007-02-05 | 2019-03-12 | Boston Scientific Scimed, Inc. | Percutaneous valve, system and method |
US8470023B2 (en) | 2007-02-05 | 2013-06-25 | Boston Scientific Scimed, Inc. | Percutaneous valve, system, and method |
EP3492043A3 (en) * | 2007-08-21 | 2019-09-04 | Symetis SA | A replacement valve |
US8414641B2 (en) | 2007-12-21 | 2013-04-09 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
US9668859B2 (en) | 2011-08-05 | 2017-06-06 | California Institute Of Technology | Percutaneous heart valve delivery systems |
US9744037B2 (en) | 2013-03-15 | 2017-08-29 | California Institute Of Technology | Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves |
CN107157621A (zh) * | 2016-09-23 | 2017-09-15 | 杭州启明医疗器械有限公司 | 一种可回收及重复定位介入器械的输送系统 |
US11331185B2 (en) * | 2016-09-23 | 2022-05-17 | Venus Medtech (Hongzhou) Inc | Delivery system facilitating retrieval of interventional device |
CN109419571A (zh) * | 2017-08-25 | 2019-03-05 | 上海微创心通医疗科技有限公司 | 自膨胀假体的输送装置及自膨胀心脏瓣膜假体的输送装置 |
CN108371570A (zh) * | 2017-10-24 | 2018-08-07 | 杭州启明医疗器械有限公司 | 一种操作稳定的介入心脏瓣膜可回收输送系统 |
CN108371570B (zh) * | 2017-10-24 | 2023-10-31 | 杭州启明医疗器械股份有限公司 | 一种操作稳定的介入心脏瓣膜可回收输送系统 |
CN108670501A (zh) * | 2018-05-07 | 2018-10-19 | 杭州启明医疗器械有限公司 | 一种便于回收介入器械的鞘管以及输送系统 |
CN108670501B (zh) * | 2018-05-07 | 2023-12-26 | 杭州启明医疗器械股份有限公司 | 一种便于回收介入器械的鞘管以及输送系统 |
Also Published As
Publication number | Publication date |
---|---|
CN1745727A (zh) | 2006-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006026912A1 (en) | An implantable artificial heart valve and implanting and retracting device | |
US11273035B2 (en) | Occluder | |
JP6242924B2 (ja) | ステント、弁付きステントおよび方法ならびにその送達システム | |
JP7136771B2 (ja) | 弁プロテーゼ送達システムと共に使用する腱索管理装置及びその使用方法 | |
US7591848B2 (en) | Riveted stent valve for percutaneous use | |
AU2015221440B2 (en) | A replacement valve | |
US7625403B2 (en) | Valved conduit designed for subsequent catheter delivered valve therapy | |
US20070244545A1 (en) | Prosthetic Conduit With Radiopaque Symmetry Indicators | |
JP5647680B2 (ja) | 一体的な迅速接続人工心臓弁ならびに配備のシステムおよび方法 | |
CN101184453B (zh) | 血流控制装置 | |
US20090099640A1 (en) | Axial Pullwire Tension Mechanism for Self-Expanding Stent | |
CN109922756A (zh) | 瓣膜递送系统 | |
JP2020501633A (ja) | 原位置で腱索を管理するための一体型変位構成要素を有する弁送達システム、及びその使用方法 | |
US20140200649A1 (en) | Systems, Methods and Devices for Retrograde Pericardial Release of a Prosthetic Heart Valve | |
US20070244546A1 (en) | Stent Foundation for Placement of a Stented Valve | |
CN106714734A (zh) | 双凸缘人工瓣膜框架 | |
CN109303626A (zh) | 主动脉瓣闭锁不全修复设备及方法 | |
CN214967138U (zh) | 升主动脉覆膜支架及输送系统组件 | |
CN109549757A (zh) | 一种介入式人工心脏瓣膜 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |